Fatal lactic acidosis and acute renal failure after addition of tenofovir to an Antiretroviral regimen containing Didanosine

被引:78
作者
Murphy, MD
O'Hearn, M
Chou, SW
机构
[1] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Infect Dis Sect, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Div Gen Internal Med, Portland, OR 97201 USA
关键词
D O I
10.1086/368313
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe a 49-year-old man with human immunodeficiency virus infection and stable chronic renal insufficiency who developed acute oliguric renal failure and severe lactic acidosis and who died several weeks after tenofovir was added to an antiretroviral regimen that included didanosine. Although the role of tenofovir in precipitating acute renal failure is unclear, progressive accumulation of the drug and pharmacologic interaction that caused increased levels of didanosine were the likely antecedents of increased mitochondrial toxicity that led to lactic acidosis.
引用
收藏
页码:1082 / 1085
页数:4
相关论文
共 12 条
[1]   Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults [J].
Barditch-Crovo, P ;
Deeks, SG ;
Collier, A ;
Safrin, S ;
Coakley, DF ;
Miller, M ;
Kearney, BP ;
Coleman, RL ;
Lamy, PD ;
Kahn, JO ;
McGowan, I ;
Lietman, PS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2733-2739
[2]   Assessment of mitochondrial toxicity in human cells treated with tenofovir: Comparison with other nucleoside reverse transcriptase inhibitors [J].
Birkus, G ;
Hitchcock, MJM ;
Cihlar, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) :716-723
[3]   Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases α,δ, and ε [J].
Birkus, G ;
Hájek, M ;
Kramata, P ;
Votruba, I ;
Holy, A ;
Otová, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1610-1613
[4]   Hyperlactatemia and antiretroviral therapy: The Swiss HIV Cohort Study [J].
Boubaker, K ;
Flepp, M ;
Sudre, P ;
Furrer, H ;
Haensel, A ;
Hirschel, B ;
Boggian, K ;
Chave, JP ;
Bernasconi, E ;
Egger, M ;
Opravil, M ;
Rickenbach, M ;
Francioli, P ;
Telenti, A .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (11) :1931-1937
[5]  
CHENG A, 2002, 9 C RETR OPP INF SEA
[6]   Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors [J].
Cihlar, T ;
Birkus, G ;
Greenwalt, DE ;
Hitchcock, MJM .
ANTIVIRAL RESEARCH, 2002, 54 (01) :37-45
[7]   Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: A report of 12 cases [J].
Coghlan, ME ;
Sommadossi, JP ;
Jhala, NC ;
Many, WJ ;
Saag, MS ;
Johnson, VA .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (11) :1914-1921
[8]   Direct analysis of mitochondrial toxicity of antiretroviral drugs [J].
Foli, A ;
Benvenuto, F ;
Piccinini, G ;
Bareggi, A ;
Cossarizza, A ;
Lisziewicz, J ;
Lori, F .
AIDS, 2001, 15 (13) :1687-1694
[9]  
*GIL SCI, 2001, VIR TEN DIS FUM PACK
[10]   Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase [J].
Johnson, AA ;
Ray, AS ;
Hanes, J ;
Suo, ZC ;
Colacino, JM ;
Anderson, KS ;
Johnson, KA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :40847-40857